CEO, Co-Founder
Nine Diagnostics
Dr. Freddy T. Nguyen, MD, PhD, is a Research Fellow at the Massachusetts Institute of Technology (MIT) and the CEO and Co-Founder of Nine Diagnostics. His research focuses on advancing functional precision medicine through the development of new technologies leveraging photonics and nanotechnologies. These efforts aim to deliver faster and more dynamic diagnostic information, enabling the selection of the most effective treatments for the right patient at the right time. Previously, his work has centered on spectroscopic techniques – such as fluorescence, Raman, diffuse reflectance, and light scattering – for cancer diagnostics and assessing therapy effectiveness.
He was previously the Transfusion Medicine Fellow in the Department of Pathology and Laboratory Medicine at Dartmouth, a Pathology Resident and Chief Resident at Mount Sinai Hospital, an Arnold O. Beckman Postdoctoral Fellow at MIT, the In Vivo Microscopy Fellow at the Wellman Center for Photomedicine at the Massachusetts General Hospital, and post-doctoral research fellow in the Department of Chemical Engineering at MIT.
He earned his Ph.D. in Chemistry from the University of Illinois at Urbana-Champaign and his M.D. from the College of Medicine at the University of Illinois at Chicago. He also conducted research at MIT‘s George R. Harrison Spectroscopy Laboratory. He holds a B.S. in Chemistry and B.A. in Mathematics from Rice University.
Tuesday, March 25, 2025
9:00am – 10:30am CT